SCHEMBL30140375

SCHEMBL30140375

CC1(Oc2ccc(Nc3ncnc4cc(F)c(O[C@H]5CCNC5)nc34)c(F)c2Cl)CC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.38
EGFR P00533 10/20 0.36
KDR P35968 7/20 0.36
FLT1 P17948 4/20 0.36
FGFR1 P11362 1/20 0.36
FLT4 P35916 1/20 0.36
EPHA2 P29317 6/20 0.35
EPHB4 P54760 5/20 0.35
ERBB2 P04626 7/20 0.35
RIPK2 O43353 1/20 0.34
RET P07949 1/20 0.34
MET P08581 1/20 0.34
EPHB2 P29323 1/20 0.34
TEC P42680 1/20 0.34
EPHA4 P54764 1/20 0.34
BTK Q06187 1/20 0.34
KCNH2 Q12809 1/20 0.34
TNK1 Q13470 1/20 0.34
RIPK3 Q9Y572 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30140272 0.87 EGFR (0.37) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140121 0.87 EGFR (0.35) GPR119EGFRKDRFLT1FGFR1
SCHEMBL30140353 0.87 KDR (0.44) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140222 0.84 GPR119 (0.35) GPR119EGFRKDRFLT1FGFR1
SCHEMBL30140107 0.84 EGFR (0.39) GPR119EGFRKDRFLT1FGFR1
SCHEMBL30140366 0.84 GPR119 (0.37) GPR119EGFRKDRFLT1FGFR1
SCHEMBL23538160 0.82 EGFR (0.45) EGFRKDRFLT1EPHA2EPHB4
SCHEMBL23538163 0.82 EGFR (0.45) EGFRKDRFLT1EPHA2EPHB4
SCHEMBL30140086 0.81 EGFR (0.35) GPR119EGFRKDRFLT1FGFR1
SCHEMBL30140412 0.81 KDR (0.43) GPR119EGFRKDRFLT1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266426-A1 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed